Greylin Investment Management, Inc - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Greylin Investment Management, Inc ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$415,000
+501.4%
18,900
+83.5%
0.08%
+372.2%
Q1 2016$69,000
-46.9%
10,300
-32.0%
0.02%
-48.6%
Q4 2015$130,000
+4.0%
15,150
-33.6%
0.04%0.0%
Q3 2015$125,000
-51.2%
22,800
-49.4%
0.04%
-46.2%
Q2 2015$256,000
+12.3%
45,100
-9.8%
0.06%
+20.4%
Q1 2015$228,0000.0%50,0000.0%0.05%0.0%
Q4 2014$228,000
-68.7%
50,000
-44.1%
0.05%
-69.0%
Q3 2014$728,000
-17.0%
89,500
-1.9%
0.17%
-17.9%
Q2 2014$877,000
-12.5%
91,200
+7.4%
0.21%
-12.8%
Q1 2014$1,002,000
+25.6%
84,900
+64.2%
0.24%
+23.4%
Q4 2013$798,00051,7000.20%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders